drugset / Trial / NCT01634295
Efficacy and Safety of CKD-828 to Stage 2 Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of present study is to evaluate the efficacy and safety of two dose combination of S-Amlodipine/Telmisartan (2.5/40mg, 2.5/80mg and 5/80mg) compared with S-Amlodipine monotherapy (2.5mg and 5mg) in patients with Stage 2 hypertension.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S-amlodipine | Unknown | 2.5 mg | — |
| Subject | S-amlodipine | Unknown | 5 mg | — |
| Subject | Telmisartan | Other / unclassified | 40 mg | — |
| Subject | Telmisartan | Other / unclassified | 80 mg | — |